Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
Supplementary file 3 provides an updated analysis of adverse event (AE) profiles for COVID-19 vaccines using VAERS case reports through June 2024. The study profiles AEs for Pfizer-BioNTech, Moderna, Janssen, bivalent, and Novavax vaccines, analyzing patterns by vaccine type, age, and sex. It employs Ontology of Adverse Events classification and statistical methods like Chi-square tests and proportional reporting ratios.
File is an XLSX spreadsheet (26.9 KB) containing analysis results, not the raw VAERS case reports. Licensed under CC BY 4.0.